SYNCOM FORMULATION (INDIA)
Sector : Pharmaceuticals and health care | Smallcap | BSE
Here's the live share price of Syncom Formulation (India) along with daily highs, lows, percentage changes and volume trends, and, all financial information.
0.28₹ 0.05
As on Sep 18, 2025, 4:01 PM IST
Syncom Formulation (India) Price Performance
Today's LowToday's High
₹17.90₹18.30
₹18.07
52 Weeks' Low52 Weeks' High
₹14.10₹24.79
₹18.07
Open Price
₹18.03
Prev. Close
₹18.02
Volume
3,60,878
Over the last 5 years, the share price of Syncom Formulation (India) has gained 61.01% CAGR. Over the past year, the corresponding return has been -22.08%.
Syncom Formulation (India)’s current P/E of 29.51x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Highest YOY Quarterly profit growth Screener.
Syncom Formulation (India) Peer Comparision
Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) |
|---|---|---|---|---|---|---|---|
| Syncom Formulation (India) | 0.33 | 5.36 | -6.52 | 15.54 | -22.08 | 26.39 | 61.01 |
| Sun Pharmaceutical Industries | 2.44 | 1.01 | 0.08 | -5.70 | -10.03 | 23.54 | 25.80 |
| Divi's Laboratories | 1.48 | -1.04 | -6.66 | 5.61 | 11.59 | 19.02 | 12.76 |
| Cipla | 1.12 | 0.89 | 5.34 | 4.62 | -4.45 | 15.11 | 14.36 |
| Torrent Pharmaceuticals | -0.61 | -2.60 | 10.27 | 13.47 | 5.88 | 33.98 | 19.88 |
| Dr. Reddy's Laboratories | 1.47 | 4.64 | 0.74 | 13.55 | 0.67 | 17.28 | 4.42 |
| Mankind Pharma | 1.47 | 6.68 | 11.93 | 22.76 | 9.94 | 22.77 | 13.10 |
| Zydus Lifesciences | 0.42 | 6.22 | 9.41 | 16.03 | -2.91 | 42.82 | 20.69 |
| Lupin | 3.09 | 4.09 | 4.93 | 0.72 | -7.84 | 47.29 | 13.56 |
| Abbott India | 0.01 | -5.05 | -1.67 | 3.97 | 11.46 | 21.23 | 13.41 |
| Aurobindo Pharma | 1.70 | 3.53 | 1.94 | -0.76 | -26.66 | 29.49 | 6.38 |
| Alkem Laboratories | 1.53 | 2.45 | 14.06 | 13.83 | -10.04 | 19.08 | 13.91 |
| Glenmark Pharmaceuticals | -0.70 | 6.98 | 27.23 | 44.88 | 28.39 | 78.62 | 32.94 |
| Laurus Labs | 3.14 | 6.66 | 39.13 | 57.29 | 90.35 | 22.06 | 25.31 |
| Biocon | 1.24 | 1.14 | 7.66 | 9.58 | 1.29 | 8.29 | -4.09 |
| Anthem Biosciences | 4.22 | 6.77 | 17.06 | 17.06 | 17.06 | 5.39 | 3.20 |
| GlaxoSmithKline Pharmaceuticals | -3.99 | -1.44 | -16.30 | -1.53 | -1.64 | 24.90 | 10.11 |
| Cohance Lifesciences | -8.13 | 1.69 | -9.19 | -19.32 | -20.15 | 25.73 | 18.74 |
| Ipca Laboratories | 2.50 | -2.87 | -1.28 | -0.09 | -6.88 | 16.19 | 4.36 |
| Gland Pharma | 2.66 | 2.34 | 16.40 | 27.61 | 9.52 | -3.50 | 2.08 |
Over the last one year, Syncom Formulation (India) has declined 22.08% compared to peers like Sun Pharmaceutical Industries (-10.03%), Divi's Laboratories (11.59%), Cipla (-4.45%). From a 5 year perspective, Syncom Formulation (India) has outperformed peers relative to Sun Pharmaceutical Industries (25.80%) and Divi's Laboratories (12.76%).
Syncom Formulation (India) Financials
Syncom Formulation (India) Stock Technicals
Moving Average
| Day | SMA | EMA |
|---|---|---|
| 5 | 17.64 | 17.81 |
| 10 | 17.38 | 17.6 |
| 20 | 17.26 | 17.53 |
| 50 | 17.94 | 17.87 |
| 100 | 18.53 | 18.15 |
| 200 | 18.44 | 18.08 |
Syncom Formulation (India) Share Holding Pattern
In the latest quarter, Syncom Formulation (India) remained same as its previous close in promoter holding, while DII stake unchanged at 0.00%, FII holding rose to 0.41%, and public shareholding moved down to 49.02% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
Syncom Formulation (India) Stock Mutual Fund Holdings
Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) |
|---|---|---|---|
| Motilal Oswal BSE Healthcare ETF | 11,042 | 0.06 | 0.02 |
Syncom Formulation (India) Corporate Actions
Date Time | Announcement |
|---|---|
| Sep 05, 2025, 1:48 AM IST | Syncom Formul. - Business Responsibility and Sustainability Reporting (BRSR) |
| Sep 05, 2025, 1:40 AM IST | Syncom Formul. - Reg. 34 (1) Annual Report. |
| Sep 05, 2025, 1:24 AM IST | Syncom Formul. - Notice Of Annual General Meeting Of Syncom Formulations (India) Limited. |
| Aug 27, 2025, 8:38 PM IST | Syncom Formul. - Intimation Regarding 100 Days Campaign - 'Saksham Niveshak' From 28Th July, 2025 To 6Th November, 2025 Updat |
| Aug 27, 2025, 8:33 PM IST | Syncom Formul. - Intimation Regarding 100 Days Campaign - 'Saksham Niveshak' From 28Th July, 2025 To 6Th November, 2025 Updat |
About Syncom Formulation (India)
Syncom Formulation (India) Ltd. is a Public Limited Listed company incorporated on 21/06/1988 and has its registered office in the State of Maharashtra, India. Company's Corporate Identification Number(CIN) is L24239MH1988PLC047759 and registration number is 047759. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company's Total Operating Revenue is Rs. 462.85 Cr. and Equity Capital is Rs. 94.00 Cr. for the Year ended 31/03/2025.
- IndustryPharmaceuticals
- Address7, Niraj Industrial Estate, Mumbai Maharashtra 400093
- Contact
Management
- Mr. Kedarmal Shankarlal BankdaExe.Chairman & W T D
- Mr. Vijay Shankarlal BankdaManaging Director
- Mrs. Rinki Ankit BankdaWhole Time Director
- Mrs. Ruchi JindalIndependent Woman Director
- Mr. Ritesh Kumar LunkadIndependent Director
- Mr. Ankit JainIndependent Director
FAQs on Syncom Formulation (India) Share Price
What is the share price of Syncom Formulation (India)?
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Syncom Formulation (India) is ₹18.07 as on Sep 18, 2025.
What kind of stock is Syncom Formulation (India)?
The Syncom Formulation (India) is operating in the Pharmaceuticals and health care Sector. It is classified as a Smallcap stock on the BSE.
What is the Market Cap of Syncom Formulation (India)?
The market cap of Syncom Formulation (India) is ₹1,698.58 Cr as on Sep 18, 2025.
What are today's High and Low prices of Syncom Formulation (India)?
Today’s highest and lowest price of Syncom Formulation (India) are ₹18.30 and ₹17.90.
What are the 52 Week High and 52 Week Low of Syncom Formulation (India)?
The 52-week high/low is the highest and lowest price at which Syncom Formulation (India) stock has traded in the past 52-week or nearly a year. The 52-week high of Syncom Formulation (India) is ₹24.79 and 52-week low of Syncom Formulation (India) is ₹14.10 as on Sep 18, 2025.
How has the Syncom Formulation (India) performed historically in terms of returns?
The Syncom Formulation (India) has shown returns of 0.28% over the past day, 5.36% for the past month, -6.52% over 3 months, -22.08% over 1 year, 26.39% across 3 years, and 61.01% over 5 years.
What are the P/E ratio, dividend yield and PB ratio of Syncom Formulation (India)?
P/E ratio of and PB ratio of Syncom Formulation (India) are 29.51 and 5.42 on Sep 18, 2025. While the company gives a dividend yield of 0.00 per annum.
Trending In Market
Stock Screener
Mutual Funds
IPO’s Open and Upcoming
Top Indices Performance
Stock Market Stats
Gold Rate Today
NSE Top Gainers
NSE Top Losers
BSE Top Gainers
BSE Top Losers
NSE 52-Week High
NSE 52-Week Low
BSE 52-Week High
BSE 52-Week Low
NSE Price Shocker
NSE Volume Shocker
BSE Price Shocker
BSE Volume Shocker
NSE Buyers
NSE Sellers
BSE Buyers
BSE Sellers
Silver Rate Today
Petrol Rate Today
Diesel Rate Today
✕
Market Data